|
Press Releases |
|
 |
|
Monday, November 27, 2023 |
|
中國旭陽集團印尼偉山順利取得出口許可並開始向全球客戶發運優質焦炭 |
全球領先的焦炭、焦化產品、精細化工產品綜合生產商及供應商及相關運營管理服務提供商中國旭陽集團有限公司(「旭陽集團」或「集團」;股份代號:1907.HK)在印度尼西亞蘇拉威西島IMIP工業園投資設立的旭陽偉山新能源(印尼)有限公司(「旭陽偉山」),正式從印尼相關政府部門取得出口許可證。 more info >> |
|
中國旭陽集團出口印尼第一船焦煤於近日交付 |
全球領先的焦炭、焦化產品、精細化工產品綜合生產商及供應商及相關運營管理服務提供商中國旭陽集團有限公司(「旭陽集團」或「集團」;股份代號:1907.HK)向印尼出口的第一船焦煤於2023年11月24日在日照港裝載完成,將於近日交付印尼旭陽偉山園區。 more info >> |
|
Friday, March 31, 2023 |
|
旭陽集團公佈2022年收入上升9.6%達人民幣431億元,股東應佔溢利為人民幣19億元 |
全球領先的焦炭、焦化產品、精細化工產品綜合生產商及供應商及相關運營管理服務提供商中國旭陽集團有限公司 (「旭陽集團」或「集團」;股份代號:1907)公佈截至2022年12月31日止年度(「報告期」)的全年業績,過去一年持續擴充全線產品年產能,深度強化高端化工產品精煉能力,以全國佈局、全球開拓致力提升市佔率。 more info >> |
|
China Risun's 2022 Revenue Ups 9.6% to RMB43.1 Billion, Profit Attributable to Owners was RMB1.9 Billion |
China Risun Group Limited ("China Risun", or the "Group", stock code: 1907), a leading global integrated coke, coking chemicals and refined chemicals producer and supplier and relevant operation management services provider in China, announced today its annual results for the year ended 31 December 2022 ("the reporting year"). more info >> |
|
Monday, August 29, 2022 |
|
旭陽集團公佈2022年中期收入上升21.1%達人民幣225.3億元,股東應佔溢利為人民幣17.4億元 |
全球領先的焦炭、焦化產品、精細化工產品綜合生產商及供應商及相關運營管理服務提供商中國旭陽集團有限公司(「旭陽集團」或「集團」;股份代號:1907)公佈截至2022年6月30日止六個月(「報告期」)的中期業績。 more info >> |
|
China Risun's 2022 Interim Revenue Ups 21.1% to RMB22.53 Billion, Profit Attributable to Owners was RMB1.74 Billion |
China Risun Group Limited ("China Risun", or the "Group", stock code: 1907), a leading global integrated coke, coking chemicals and refined chemicals producer and supplier and relevant operation management services provider in China, has announced its interim results for the six months ended 30 June 2022 ("the reporting period"). more info >> |
|
Monday, March 28, 2022 |
|
旭陽集團公佈2021年全年股東應佔溢利上升約58.1%至人民幣26.13億元 |
全球領先的焦炭、焦化產品、精細化工產品綜合生產商及供應商及相關運營管理服務提供商中國旭陽集團有限公司 (「旭陽集團」或「集團」;股份代號:1907)公佈截至2021年12月31日止年度(「報告期」)的全年業績,股東應佔溢利上升約58.1%至人民幣26.1億元,自2019年上市以來連續3年保持增長。 more info >> |
|
China Risun's 2021 Annual Profit Attributable to Owners Ups 58.1% to RMB2.61 billion |
China Risun Group Limited ("China Risun", or the "Group", stock code: 1907), a leading global integrated coke, coking chemicals and refined chemicals producer and supplier and relevant operation management services provider in China more info >> |
|
Tuesday, November 2, 2021 |
|
旭阳集团股份获股东及高管连番增持显信心 |
全球领先的焦炭、焦化产品、精细化工产品综合生产商及供货商及相关运营管理服务提供商中国旭阳集团有限公司 (「旭阳集团」或「集团」;股份代号:1907)近日获得多位重要股东及高管连番增持,突显对公司发展前景之信心。 more info >> |
|
旭陽集團股份獲股東及高管連番增持顯信心 |
全球領先的焦炭、焦化產品、精細化工產品綜合生產商及供應商及相關運營管理服務提供商中國旭陽集團有限公司 (「旭陽集團」或「集團」;股份代號:1907)近日獲得多位重要股東及高管連番增持,突顯對公司發展前景之信心。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Galaxy Payroll Group and Euler Number Limited Announce Strategic Partnership to Transform HR and Payroll Solutions
Feb 28, 2025 22:17 HKT/SGT
|
|
|
曹操智行自動駕駛平台上線 構建國內首個"F立方"全域自研閉環智駕生態
Feb 28, 2025 19:11 HKT/SGT
|
|
|
Q2 Metals Announces Warrant Exercise for $7.6 Million
Feb 28, 2025 18:38 HKT/SGT
|
|
|
曹操智行自动驾驶平台上线 构建国内首个"F立方"全域自研闭环智驾生态
Feb 28, 2025 18:35 HKT/SGT
|
|
|
持續深耕國際市場 乘用車頭部企業奇瑞汽車遞交港股上市申請
Feb 28, 2025 18:14 HKT/SGT
|
|
|
Galaxy Payroll Group and Euler Number Limited Announce Strategic Partnership to Transform HR and Payroll Solutions
Feb 28, 2025 18:04: JST
|
|
|
AEON Credit Secures HK$300 Million Syndicated Sustainability-Linked Loan
Feb 28, 2025 17:55 HKT/SGT
|
|
|
AEON信貸財務獲3億港元可持續發展表現掛鈎銀團貸款
Feb 28, 2025 17:44 HKT/SGT
|
|
|
AEON信贷财务获3亿港元可持续发展表现挂钩银团贷款
Feb 28, 2025 17:30 HKT/SGT
|
|
|
Fujitsu's Oyama plant achieves top CSR score for sustainability in global telecom audit
Feb 28, 2025 16:57 JST
|
|
|
HKTDC welcomes Hong Kong SAR's 2025-26 Budget
Feb 28, 2025 15:54 HKT/SGT
|
|
|
Honda、軽二輪スーパースポーツモデル「CBR250RR」のカラーバリエーションを変更し発売
Feb 28, 2025 15:00: JST
|
|
|
三菱重工、ポジティブ・インパクト・ファイナンス融資契約を締結
Feb 28, 2025 15:00: JST
|
|
|
The 17th Annual Global CSR & ESG Summit 2025 Concludes in Ho Chi Minh City, Setting New Standards in Sustainability
Feb 28, 2025 11:56: JST
|
|
|
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone
Feb 28, 2025 12:31 JST
|
|
|
|
More News >> |
|
|
|
|
|